Clinical Trial Update: Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated cyclosporine A for treating hypertrophic cardiomyopathy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Cyclosporine A (cyclosporine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiomyopathy, Hypertrophic, Heart Hypertrophy | Phase 2 | Status: COMPLETED